Clinical study of pranlukast as early seasonal treatment for Japanese cedar pollinosis
Phase 4
- Conditions
- Japanese cedar pollinosis
- Registration Number
- JPRN-UMIN000000583
- Lead Sponsor
- Group study of Early Intervention of Pollinosis with Pranlukast
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) any other disease, nasal polyp, acute/chronic rhinitis, sinusitis et al 2) use of any anti-histamine drugs, anti-allergy drugs, nasal steroid drugs et al at the beginning of the study 3) buildup phase of immunotherapy to Japanese cedar pollen 4) pregnancy, potential pregnancy, or lactation 5) the others, inappropriate to this study by the judgment of doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptom-medication score (symptomscore+medication score)
- Secondary Outcome Measures
Name Time Method Symptom score (stuffy nose,runny nose, sneezing,eye itchiness and tearing), medication score and QOL Questionaire score(JRQLQ No1)